Cargando…
Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
Treatment of glioblastoma xenografts with chloroquine results in macroautophagy/autophagy inhibition, resulting in a reduction of tumor hypoxia and sensitization to radiation. Preclinical data show that EGFRvIII-expressing glioblastoma may benefit most from chloroquine because of autophagy dependenc...
Autores principales: | Compter, Inge, Eekers, Danielle B. P., Hoeben, Ann, Rouschop, Kasper M. A., Reymen, Bart, Ackermans, Linda, Beckervordersantforth, Jan, Bauer, Noel J. C., Anten, Monique M., Wesseling, Pieter, Postma, Alida A., De Ruysscher, Dirk, Lambin, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496728/ https://www.ncbi.nlm.nih.gov/pubmed/32866424 http://dx.doi.org/10.1080/15548627.2020.1816343 |
Ejemplares similares
-
Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response
por: Verduin, Maikel, et al.
Publicado: (2018) -
Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions
por: Hartgerink, Dianne, et al.
Publicado: (2018) -
Neurocognition in adults with intracranial tumors: does location really matter?
por: Sleurs, Charlotte, et al.
Publicado: (2022) -
Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain
por: Zegers, C.M.L., et al.
Publicado: (2023) -
Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study
por: Broen, Martinus P G, et al.
Publicado: (2022)